1 Das, UN (2008) Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease – but how and why? Prostaglandins Leukot Essent Fatty Acids 78, 11–19.
2 Kidd, PM (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural–functional synergies with cell membrane phospholipids. Altern Med Rev 12, 207–227.
3 Su, KP (2009) Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a ‘mind-body interface’? Neurosignals 17, 144–152.
4 Salem, N Jr, Litman, B, Kim, HY, et al. (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36, 945–959.
5 Valenzuela, A (2009) Docosahexaenoic acid (DHA), an essential fatty acid for the proper functioning of neuronal cells: their role in mood disorders. Grasas Y Aceites 60, 203–212.
6 Farooqui, AA, Ong, WY & Horrocks, LA (2006) Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58, 591–620.
7 Edwards, R, Peet, M, Shay, J, et al. (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48, 149–155.
8 Hibbeln, JR (1998) Fish consumption and major depression. Lancet 351, 1213.
9 Tanskanen, A, Hibbeln, JR, Tuomilehto, J, et al. (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52, 529–531.
10 Adams, PB, Lawson, S, Sanigorski, A, et al. (1996) Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31, S157–S161.
11 McNamara, RK, Hahn, CG, Jandacek, R, et al. (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 62, 17–24.
12 Peet, M, Murphy, B, Shay, J, et al. (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43, 315–319.
13 Nemets, B, Stahl, Z & Belmaker, RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477–479.
14 Peet, M & Horrobin, DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913–919.
15 Su, KP, Huang, SY, Chiu, CC, et al. (2003) Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13, 267–271.
16 Freeman, MP, Hibbeln, JR, Wisner, KL, et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954–1967.
17 Lin, PY & Su, KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68, 1056–1061.
18 Marangell, LB, Martinez, JM, Zboyan, HA, et al. (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996–998.
19 Rogers, PJ, Appleton, KM, Kessler, D, et al. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 99, 421–431.
20 Silvers, KM, Woolley, CC, Hamilton, FC, et al. (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72, 211–218.
21 Al, MD, van Houwelingen, AC, Kester, AD, et al. (1995) Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 74, 55–68.
22 Holman, RT, Johnson, SB & Ogburn, PL (1991) Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 88, 4835–4839.
23 Otto, SJ, van Houwelingen, AC, Badart-Smook, A, et al. (2001) Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. Am J Clin Nutr 73, 1074–1079.
24 Al, MD, van Houwelingen, AC & Hornstra, G (2000) Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 71, 285S–291S.
25 Hibbeln, JR & Salem, N Jr (1995) Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62, 1–9.
26 Evans, J, Heron, J, Francomb, H, et al. (2001) Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323, 257–260.
27 O'Hara, MW & Swain, AM (1996) Rates and risk of postpartum depression – a meta-analysis. Int Rev Psychiatry 8, 37–54.
28 Makrides, M, Neumann, MA & Gibson, RA (1996) Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 50, 352–357.
29 Hibbeln, JR (2002) Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69, 15–29.
30 Golding, J, Steer, C, Emmett, P, et al. (2009) High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 20, 598–603.
31 De Vriese, SR, Christophe, AB & Maes, M (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73, 3181–3187.
32 Browne, JC, Scott, KM & Silvers, KM (2006) Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 90, 131–139.
33 Miyake, Y, Sasaki, S, Yokoyama, T, et al. (2006) Risk of postpartum depression in relation to dietary fish and fat intake in Japan: the Osaka Maternal and Child Health Study. Psychol Med 36, 1727–1735.
34 Strom, M, Mortensen, EL, Halldorsson, TI, et al. (2009) Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort. Am J Clin Nutr 90, 149–155.
35 Mattes, E, McCarthy, S, Gong, G, et al. (2009) Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain Behav Immun 23, 380–388.
36 Krauss-Etschmann, S, Shadid, R, Campoy, C, et al. (2007) Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am J Clin Nutr 85, 1392–1400.
37 Chiu, CC, Huang, SY, Shen, WW, et al. (2003) Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry 160, 385.
38 Freeman, MP, Hibbeln, JR, Wisner, KL, et al. (2006) Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 113, 31–35.
39 Freeman, MP, Hibbeln, JR, Wisner, KL, et al. (2006) An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatrica 18, 21–24.
40 Marangell, LB, Martinez, JM, Zboyan, HA, et al. (2004) Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress Anxiety 19, 20–23.
41 Doornbos, B, van Goor, SA, Dijck-Brouwer, DA, et al. (2009) Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry 33, 49–52.
42 Freeman, MP, Davis, M, Sinha, P, et al. (2008) Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 110, 142–148.
43 Llorente, AM, Jensen, CL, Voigt, RG, et al. (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188, 1348–1353.
44 Rees, AM, Austin, MP & Parker, GB (2008) Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 42, 199–205.
45 Su, KP, Huang, SY, Chiu, TH, et al. (2008) Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69, 644–651.
46 Dunstan, JA, Mori, TA, Barden, A, et al. (2004) Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58, 429–437.
47 Freeman, MP, Hibbeln, JR, Wisner, KL, et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954–1967.
48 Appleton, KM, Hayward, RC, Gunnell, D, et al. (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84, 1308–1316.
49 Appleton, KM, Rogers, PJ & Ness, AR (2010) Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 91, 757–770.
50 Thase, ME (1999) How should efficacy be evaluated in randomized clinical trials of treatments for depression? J Clin Psychiatry 60, Suppl. 4, 23–31.